STERITEK INC
10-Q/A, 1996-07-17
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Previous: CALENERGY CO INC, S-3, 1996-07-17
Next: WATER JEL TECHNOLOGIES INC, SC 13D, 1996-07-17



                           UNITED STATES

                SECURITIES AND EXCHANGE COMMISSION

                    Washington, D.C.   20549

                            FORM 10-Q/A
                          AMENDMENT NO. 1

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED            MARCH 31, 1996

Commission file number  0-12547

                         Steritek, Inc.                    
     (Exact name of registrant as specified in its charter)

         New Jersey                         22-2243703     
(State or other jurisdiction of          (I.R.S. Employer
incorporation or organization)          Identification No.)

                      121 Moonachie Avenue
                      Moonachie, NJ  07074          
            (Address of principal executive offices)
                           (Zip Code)

                        (201) 460-0500                          
   (Registrant's telephone number, including area code)      
                                                               
(Former name, former address and former fiscal year, if changed
                       since last report)

     Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days.

                            Yes [X]   No [ ]        

        APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
          PROCEEDINGS DURING THE PRECEDING FIVE YEARS:
     Indicate by check mark whether the registrant has filed all
documents and reports required to be filed by Sections 12, 13, or
15(d) of the Securities Exchange act of 1934 subsequent to the
distribution of securities under a plan confirmed by a court.
                           Yes [ ]   No [ ]       

              APPLICABLE ONLY TO CORPORATE ISSUERS:
     Indicate the number of shares outstanding of each of the
issuer's classes of common stock, as of the latest practicable
date:  3,586,285 shares of Common Stock on March 1, 1996
<PAGE>
Item 6.  Exhibits and Reports on Form 8-K.

     (a)  Exhibits


     27.    Financial Data Schedule
<PAGE>
                 STERITEK, INC. AND SUBSIDIARIES
     
                            SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

                                Steritek, Inc.              


                              By/s/ James K. Wozniak
                                                                  
 
                                James K. Wozniak, Vice President,
                                 Chief Financial Officer and 
                                 Secretary (principal financial
                                 and accounting officer)         
                    
Date:  July 17, 1996


<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM STERITEK,
INC. AND SUBSIDIARIES (UNAUDITED) CONSOLIDATED FINANCIAL STATEMENTS
INCLUDED IN ITS FORM 10-Q FOR THE QUARTER ENDED MARCH 31, 1996 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>
<MULTIPLIER> 1
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUN-30-1996
<PERIOD-END>                               MAR-31-1996
<CASH>                                         487,073
<SECURITIES>                                         0
<RECEIVABLES>                                  418,818
<ALLOWANCES>                                     4,895
<INVENTORY>                                    114,145
<CURRENT-ASSETS>                             1,388,223
<PP&E>                                       2,679,314
<DEPRECIATION>                               1,602,802
<TOTAL-ASSETS>                               2,886,149
<CURRENT-LIABILITIES>                          341,901
<BONDS>                                        716,183
                                0
                                          0
<COMMON>                                       640,844
<OTHER-SE>                                   1,187,221
<TOTAL-LIABILITY-AND-EQUITY>                 2,886,149
<SALES>                                      3,943,713
<TOTAL-REVENUES>                             4,219,811
<CGS>                                        1,987,562
<TOTAL-COSTS>                                1,987,562
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              46,259
<INCOME-PRETAX>                                193,796
<INCOME-TAX>                                    53,903
<INCOME-CONTINUING>                            139,893
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   139,893
<EPS-PRIMARY>                                      .04
<EPS-DILUTED>                                      .03

        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission